Every SEC Form 3/4/5 on record for this filer (CIK 1269340) — 6 issuers, 66 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PAVM | PAVmed Inc. | President and CFO | 2017-03-21 → 2026-04-03 | 15 | $55,675 |
| LUCD | Lucid Diagnostics Inc. | Chief Financial Officer | 2021-10-13 → 2026-02-24 | 6 | — |
| CTOR | CITIUS ONCOLOGY, INC. | Director | 2024-08-14 → 2025-12-22 | 6 | — |
| DRIO | DarioHealth Corp. | Director | 2016-03-03 → 2025-09-15 | 27 | −$1M |
| CTXR | Citius Pharmaceuticals, Inc. | Director | 2023-02-09 → 2024-11-12 | 4 | — |
| FCRE | FC Global Realty Inc | Director · lapsed | 2017-12-27 → 2017-12-28 | 2 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
5 of 6 issuers are covered and open a security page; the rest are on file here only.